Frontiers in Cancer Biotechnology Research

Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.

Research Articles

The Epigenetic Key: How a Novel Compound Unlocks Cancer's Weaknesses

Discover how KBH-A42, a novel HDAC inhibitor, selectively targets leukemia cells through epigenetic reprogramming and gene expression changes.

Chloe Mitchell
Aug 08, 2025

Popular Articles